PATENT CLAIM ANALYSIS

Application Number: 16156447
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-08
Patent Classification: ["514", "287000"]

Abstract:
The invention relates to compound of the formula (I′) or a salt thereof, wherein the substituents are as defined in the specification; to its preparation, to its use as medicament and to medicaments comprising it.

Claim (Index 12):
The method of  claim 11 , wherein the disease is selected from hemophilia A, hemophilia B, cystic fibrosis, mucopolysaccharidosis I, Duchenne Muscle Dystrophy, Becker Muscle Dystrophy, loss of APC caused cancer and loss of p53 caused cancer.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 97.0
- Lexical Diversity: 1.24242
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14728613', '14652102', '15554801', '15315582', '14763468']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7560620997144584
- 35 USC 102 Novelty (BERT): 0.584174026342812
- Combined Prediction Score: 0.7388732923772937
- Mean Citation Score: 382.642246
- Max Citation Score: 668.1334
- Similarity Product: 353.5247943449498

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test